abstract |
The present invention relates to combinations of A) oxazolidinones of the formula (I) and B) acetylsalicylic acid (aspirin) and C) an ADP receptor antagonist, in particular P 2 Y 12 purine receptor blocker, a process for producing these combinations and their use as Medicaments, in particular for the prophylaxis and / or treatment of thromboembolic disorders. |